Changes in plasma lipids predict pravastatin efficacy in secondary prevention-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Changes in plasma lipids predict pravastatin efficacy in secondary prevention

Published:2019-07-11 Issue:13 Volume:4 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Jayawardana Kaushala S.,Mundra Piyushkumar A.,Giles Corey^ORCID,Barlow Christopher K.,Nestel Paul J.,Barnes Elizabeth H.,Kirby Adrienne,Thompson Peter,Sullivan David R.,Alshehry Zahir H.,Mellett Natalie A.,Huynh Kevin^ORCID,McConville Malcolm J.^ORCID,Zoungas Sophia,Hillis Graham S.^ORCID,Chalmers John^ORCID,Woodward Mark,Marschner Ian C.,Wong Gerard,Kingwell Bronwyn A.,Simes John,Tonkin Andrew M.,Meikle Peter J.

Funder

the National Health and Medical Research Council of Australia

the Operational Infrastructure Support Program of the Victorian government of Australia

Bristol-Myers Squibb

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/128438/files/pdf

Reference28 articles.

1. Lipid modifying agents: mechanisms of action and reduction of cardiovascular disease;Scott;Clin Exp Pharmacol Physiol,1997

2. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

3. Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

4. Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study;White;J Am Heart Assoc,2013

5. High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipidomic profiling in patients with familial hypercholesterolemia: Abnormalities in glycerolipids and oxysterols;Clinical Biochemistry;2024-10

2. Phospholipid biomarkers of coronary heart disease;Journal of Pharmaceutical Health Care and Sciences;2024-05-11

3. Gestational testosterone excess early to mid-pregnancy disrupts maternal lipid homeostasis and activates biosynthesis of phosphoinositides and phosphatidylethanolamines in sheep;Scientific Reports;2024-03-14

4. Imputation of plasma lipid species to facilitate integration of lipidomic datasets;Nature Communications;2024-02-20

5. Statins—From Fungi to Pharmacy;International Journal of Molecular Sciences;2023-12-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3